Durvalumab

PACIFIC Trial Shows Results for Lung Cancer: AstraZeneca’s Durvalumab

Jul 24, 2019 | Durvalumab, Lung Cancer, Non-Small Cell Lung Cancer, NSCLC

The Phase III PACIFIC trial has made significant progress on the treatment of locally advanced non-small cell lung cancer (NSCLC) when both the progression-free survival (PFS) and overall survival (OS) results were announced separately. 3 years later with updated...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

PACIFIC Trial Shows Results for Lung Cancer: AstraZeneca’s Durvalumab

Pin It on Pinterest